Why 94% of B2B Survey Panels Fail Basic Fraud Detection — And What CalibraSync Does Differently
A frank examination of why the market research industry's quality crisis persists — and how a multi-layer verification architecture produces data that research professionals can actually rely on.
How to Identify Genuine B2B Decision-Makers Before Your Survey Launches
Six structural red flags and the verification checkpoints every research brief should specify.
The Complete Guide to HIPAA-Compliant Physician Panel Research in 2026
What IRB-appropriate methodology actually looks like — and why most panels aren't as compliant as they claim.
B2B vs. Consumer Panels: What Every Researcher Must Know Before Selecting Sample
Structural differences that fundamentally change how sample should be sourced, verified, and compensated.
Pharmaceutical Market Research in 2026: What's Changed, What Hasn't, What's Next
AI-generated responses, NPI fraud, and tighter IRB requirements are reshaping pharma's approach to HCP panels.
Device Fingerprinting in Survey Research: How CalibraSync Detects What Screeners Miss
Device-level intelligence catches fraud that traditional screeners will never surface.
GDPR and B2B Market Research in 2026: A Practical Guide for Research Agencies
Three years of enforcement actions have clarified what GDPR actually requires for B2B survey panels.
Understanding Incidence Rate in B2B Research: Why a 20% IR Isn't What You Think
IR in B2B research is one of the most misunderstood metrics — with direct consequences for budgeting and timelines.
Oncology Market Research: Reaching Verified Specialists for Phase II and III Drug Studies
Oncologists are among the most valuable and hardest-to-reach respondents. Here's what verified recruitment actually requires.